Clinical Trial Update: The Effects of Corneal Collagen Cross-linking [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on corneal collagen cross-linking for corneal ectasia disorders including keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia Disorders Including Keratoconus

Snippet

Sponsor: Rush Eye Associates | Conditions: Corneal Ectasia Disorders Including Keratoconus | Phase 3 | Status: UNKNOWN